Greg Galler

5.0k total citations · 2 hit papers
13 papers, 2.4k citations indexed

About

Greg Galler is a scholar working on Hepatology, Epidemiology and Gastroenterology. According to data from OpenAlex, Greg Galler has authored 13 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hepatology, 7 papers in Epidemiology and 3 papers in Gastroenterology. Recurrent topics in Greg Galler's work include Hepatitis C virus research (7 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hepatitis B Virus Studies (5 papers). Greg Galler is often cited by papers focused on Hepatitis C virus research (7 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hepatitis B Virus Studies (5 papers). Greg Galler collaborates with scholars based in United States, Philippines and Japan. Greg Galler's co-authors include Asher Kornbluth, Joel J. Bauer, D. H. Present, Irwin M. Gelernt, Fabrizio Michelassi, Stephen B. Hanauer, Simon Lichtiger, Jonathan McCone, Clifford A. Brass and Andrew J. Muir and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and Hepatology.

In The Last Decade

Greg Galler

13 papers receiving 2.3k citations

Hit Papers

Cyclosporine in Severe Ulcerative Colitis Refractory to S... 1994 2026 2004 2015 1994 2009 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid Therapy
    1994 1.3k citations Simon Lichtiger, D. H. Present et al. New England Journal of Medicine profile →
  2. Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
    2009 889 citations John G. McHutchison, Eric Lawitz et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Greg Galler United States 9 1.7k 1.2k 1.1k 381 210 13 2.4k
Frank Anderson Canada 23 2.3k 1.3× 1.3k 1.1× 1.5k 1.4× 969 2.5× 361 1.7× 64 3.7k
Marte Lie Høivik Norway 21 1.0k 0.6× 316 0.3× 1.0k 1.0× 435 1.1× 81 0.4× 63 1.8k
Joep de Bruijne Netherlands 16 754 0.4× 464 0.4× 600 0.5× 253 0.7× 188 0.9× 47 1.6k
R. Sostegni Italy 22 1.8k 1.0× 251 0.2× 2.1k 1.9× 1.0k 2.7× 97 0.5× 44 2.6k
D. H. Present United States 6 1.1k 0.6× 179 0.2× 1.4k 1.3× 505 1.3× 80 0.4× 11 1.7k
L. Pagliaro Italy 24 1.7k 1.0× 1.7k 1.4× 195 0.2× 773 2.0× 55 0.3× 74 2.5k
Fiorella Balli Italy 17 754 0.4× 511 0.4× 149 0.1× 354 0.9× 212 1.0× 34 1.3k
M. Chiaramonte Italy 26 1.5k 0.8× 1.5k 1.3× 135 0.1× 199 0.5× 199 0.9× 96 2.1k
G. S. A. McDonald Ireland 17 881 0.5× 928 0.8× 148 0.1× 571 1.5× 94 0.4× 50 1.7k
Neena Sood India 18 606 0.3× 201 0.2× 409 0.4× 405 1.1× 122 0.6× 112 1.4k

Countries citing papers authored by Greg Galler

Since Specialization
Citations

This map shows the geographic impact of Greg Galler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Galler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Galler more than expected).

Fields of papers citing papers by Greg Galler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Greg Galler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Galler. The network helps show where Greg Galler may publish in the future.

Co-authorship network of co-authors of Greg Galler

This figure shows the co-authorship network connecting the top 25 collaborators of Greg Galler. A scholar is included among the top collaborators of Greg Galler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Greg Galler. Greg Galler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Melia, Michael T., Norbert Bräu, Fred Poordad, et al.. (2014). Infections During Peginterferon/Ribavirin Therapy Are Associated With the Magnitude of Decline in Absolute Lymphocyte Count: Results of the IDEAL Study. Clinical Infectious Diseases. 58(7). 960–969. 8 indexed citations
2.
Dupont, Andrew, Zhi‐Dong Jiang, Ned Snyder, et al.. (2014). Motility Abnormalities in Irritable Bowel Syndrome. Digestion. 89(2). 119–123. 44 indexed citations
3.
Jiang, Zhi‐Dong, Andrew Dupont, Herbert L. DuPont, et al.. (2012). Su2074 Genetic Polymorphisms in Serotonin Transporter and G-Protein Genes in Patients With Irritable Bowel Syndrome. Gastroenterology. 142(5). S–562. 1 indexed citations
4.
Melia, Michael T., Andrew J. Muir, Jonathan McCone, et al.. (2011). Racial differences in hepatitis C treatment eligibility. Hepatology. 54(1). 70–78. 36 indexed citations
5.
DuPont, Herbert L., Greg Galler, Francisco García‐Torres, et al.. (2010). Travel and Travelers' Diarrhea in Patients with Irritable Bowel Syndrome. American Journal of Tropical Medicine and Hygiene. 82(2). 301–305. 24 indexed citations
6.
Sulkowski, Mark, Stephen A. Harrison, Lorenzo Rossaro, et al.. (2010). Impaired Fasting Glucose Is Associated With Lower Rates of Sustained Virologic Response (SVR) in Patients With Genotype 1 Chronic Hepatitis C (CHC): Retrospective Analysis of the IDEAL Study. 2 indexed citations
7.
Vierling, John M., Robert Ralston, E.J. Lawitz, et al.. (2010). 2016 LONG-TERM OUTCOMES FOLLOWING COMBINATION TREATMENT WITH BOCEPREVIR PLUS PEG-INTRON/RIBAVIRIN (P/R) IN PATIENTS WITH CHRONIC HEPATITIS C, GENOTYPE 1 (CHC-G1). Journal of Hepatology. 52. S470–S471. 21 indexed citations
8.
McHutchison, John G., Eric Lawitz, Mitchell L. Shiffman, et al.. (2009). Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection. New England Journal of Medicine. 361(6). 580–593. 889 indexed citations breakdown →
9.
Sulkowski, Mark, E. Läwitz, M. Shiffman, et al.. (2008). 991 FINAL RESULTS OF THE IDEAL (INDIVIDUALIZED DOSING EFFICACY VERSUS FLAT DOSING TO ASSESS OPTIMAL PEGYLATED INTERFERON THERAPY) PHASE IIIB STUDY. Journal of Hepatology. 48. S370–S371. 29 indexed citations
10.
Poordad, Fred, Norbert Bräu, Eric Lawitz, et al.. (2008). Hematologic Safety Data From the IDEAL Trial: Neutropenia, Anemia, and Thrombocytopenia Profiles of Peginterferon alfa/Ribavirin. 1 indexed citations
11.
Jacobson, Ira M., Robert S. Brown, Jonathan McCone, et al.. (2007). Impact of weight-based ribavirin with peginterferon alfa-2b in african americans with hepatitis C virus genotype 1. Hepatology. 46(4). 982–990. 55 indexed citations
12.
Galler, Greg, et al.. (1996). Splenic arteriovenous fistula. Digestive Diseases and Sciences. 41(4). 816–819. 17 indexed citations
13.
Lichtiger, Simon, D. H. Present, Asher Kornbluth, et al.. (1994). Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid Therapy. New England Journal of Medicine. 330(26). 1841–1845. 1267 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frank Anderson Breakdown of academic impact, for papers by Marte Lie Høivik Breakdown of academic impact, for papers by Joep de Bruijne Breakdown of academic impact, for papers by R. Sostegni Breakdown of academic impact, for papers by D. H. Present Breakdown of academic impact, for papers by L. Pagliaro Breakdown of academic impact, for papers by Fiorella Balli Breakdown of academic impact, for papers by M. Chiaramonte Breakdown of academic impact, for papers by G. S. A. McDonald Breakdown of academic impact, for papers by Neena Sood
Rankless by CCL
2026